E-LIB Suche - Ergebnisse für: Nappi, Anna

1

Heterogeneous disease and intermittent treatment in metasta..:

De Stefano, Alfonso ; Zanaletti, Nicoletta ; Cassata, Antonino...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

Bayesian Network Analysis for Prediction of Unplanned Hospi..:

Cascella, Marco ; Racca, Emanuela ; Nappi, Anna...
Healthcare. 10 (2022) 10 - p. 1853 , 2022

Link: https://doi.org/10.3390/..

3

Aflibercept or bevacizumab in combination with FOLFIRI as s..:

Ottaiano, Alessandro ; Scala, Stefania ; Santorsola, Mariachiara...
Therapeutic Advances in Medical Oncology. 13 (2021) - p. 175883592198922 , 2021

Link: https://doi.org/10.1177/..

4

Randomized phase II study of valproic acid in combination w..:

Avallone, Antonio ; Piccirillo, Maria Carmela ; Di Gennaro, Elena...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592092958 , 2020

Link: https://doi.org/10.1177/..

5

Study of Ras Mutations' Prognostic Value in Metastatic Colo..:

Ottaiano, Alessandro ; Normanno, Nicola ; Facchini, Sergio...
Cancers. 12 (2020) 7 - p. 1919 , 2020

Link: https://doi.org/10.3390/..

6

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumu..:

Piccirillo, Maria Carmela ; Avallone, Antonio ; Carlomagno, Chiara...
Clinical Colorectal Cancer. 19 (2020) 4 - p. 270-276 , 2020

Link: https://doi.org/10.1016/..

7

Cetuximab, irinotecan and fluorouracile in fiRst-line treat..:

Ottaiano, Alessandro ; Scala, Stefania ; Normanno, Nicola...
BMC Cancer. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

8

Exploratory findings from a prematurely closed internationa..:

Cardone, Claudia ; Martinelli, Erika ; Troiani, Teresa...
ESMO Open. 4 (2019) 4 - p. e000519 , 2019

Link: https://doi.org/10.1136/..

9

First Biologic Drug in the Treatment of RAS Wild-Type Metas..:

Ottaiano, Alessandro ; De Stefano, Alfonso ; Capozzi, Monica...
Frontiers in Pharmacology. 9 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

10

Integration of stereotactic radiotherapy in the treatment o..:

Ottaiano, Alessandro ; Scotti, Valerio ; De Divitiis, Chiara...
Oncotarget. 9 (2018) 81 - p. 35251-35265 , 2018

Link: https://doi.org/10.18632..

11

Clinical outcome and molecular characterisation of chemoref..:

Martinelli, Erika ; Sforza, Vincenzo ; Cardone, Claudia...
ESMO Open. 2 (2017) 3 - p. e000177 , 2017

Link: https://doi.org/10.1136/..

12

Case 1 – Successful resection after FOLFIRI plus cetuximab ..:

Loupakis, Fotios ; Nasti, Gugliemo ; Romano, Carmela.
Cancer Breaking News. 5 (2017) 3 - p. 30-35 , 2017

Link: https://doi.org/10.19156..

13

Clinical activity and tolerability of FOLFIRI and cetuximab..:

Martinelli, E. ; Cardone, C. ; Troiani, T....
ESMO Open. 1 (2016) 6 - p. e000086 , 2016

Link: https://doi.org/10.1136/..

14

Limits and potential of targeted sequencing analysis of liq..:

Rachiglio, Anna Maria ; Abate, Riziero Esposito ; Sacco, Alessandra...
Oncotarget. 7 (2016) 41 - p. 66595-66605 , 2016

Link: https://doi.org/10.18632..

15

AXL is an oncotarget in human colorectal cancer:

Martinelli, Erika ; Martini, Giulia ; Cardone, Claudia...
Oncotarget. 6 (2015) 27 - p. 23281-23296 , 2015

Link: https://doi.org/10.18632..